Previous close | 304.59 |
Open | 300.61 |
Bid | 314.50 x 0 |
Ask | 314.72 x 0 |
Day's range | 305.02 - 315.00 |
52-week range | 253.48 - 325.00 |
Volume | |
Avg. volume | 3,774,036 |
Market cap | 381.082B |
Beta (5Y monthly) | 0.08 |
PE ratio (TTM) | 31.27 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 8.80 (2.89%) |
Ex-dividend date | 22 Nov 2023 |
1y target est | N/A |
Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.